Coinfection

Short Course of Tuberculosis Therapy Effective for HIV Patients

Published in TB and Outbreaks Week, May 9th, 2000

Scientists report that a study comparing long-term versus short-term therapy for preventing tuberculosis in patients with HIV shows the latter to be a safe and effective method of treatment.

The study was reported in a recent edition of the Journal of the American Medical Association ("Rifampin and pyrazinamide vs. isoniazid for prevention of tuberculosis in HIV-infected persons - An international randomized trial," JAMA, 2000;283(11):1445-1450).

More than 1,500 HIV patients with a positive tuberculin skin test were enrolled in the study. According to F. Gordin and colleagues at the Veteran Affairs Medical Center in Washington, DC,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2000-05-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry